Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC).

Abstract

Sixty-four SCLC patients (44 males and 20 females, median age 60 years, median PS 60%) were treated with an IEP regimen. Forty-nine cases were evaluable, 35 cases were limited disease (LD) and 14 cases were extensive disease (ED). Treatment consisted of ifosfamide 1.5 g/m2 i.v. infusion for 4 h on days 1 and 2 with mesna uroprotection; epirubicin 60 mg/m2 i… (More)

Topics

Cite this paper

@article{Thongprasert1993IfosfamideEA, title={Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC).}, author={Sumitra Thongprasert and K Jiamsriponges}, journal={Lung cancer}, year={1993}, volume={10 1-2}, pages={91-4} }